P53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner

PLoS ONE

Volumn 3, Issue 11, 2008, Pages

  Molchadsky, Alina ^a   Shats, Igor ^a   Goldfinger, Naomi ^a   Pevsner Fischer, Meirav ^a   Olson, Melissa ^b   Rinon, Ariel ^a   Tzahor, Eldad ^a   Lozano, Guillermina ^b   Zipori, Dov ^a   Sarig, Rachel ^a   Rotter, Varda ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR; MYOCARDIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; MESENCHYME CELL; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; ANIMAL; CELL CULTURE; CELL LINEAGE; COMPARATIVE STUDY; CYTOLOGY; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; MOUSE MUTANT; OSTEOBLAST; PHYSIOLOGY;

ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; NUCLEAR PROTEINS; OSTEOBLASTS; OSTEOGENESIS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 56649118849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003707     Document Type: Article

References (63)

1. Lane DP (1992) p53, guardian of the genome. Nature 358: 15-16.
2. el-Deiry WS (1998) Regulation of p53 downstream genes. Semin Cancer Biol 8: 345-357.
3. Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442.
4. Ho J, Benchimol S (2003) Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 10: 404-408.
5. Vousden KH (2000) p53: death star. Cell 103: 691-694.
6. Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908.
7. Teodoro JG, Branton PE (1997) Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J Virol 71: 3620-3627.
8. Roger L, Gadea G, Roux P (2006) Control of cell migration: a tumour suppressor function for p53? Biol Cell 98: 141-152.
9. Bensaad K, Vousden KH (2007) p53: new roles in metabolism. Trends Cell Biol 17: 286-291.
10. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, et al. (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-134.
11. Stiewe T (2007) The p53 family in differentiation and tumorigenesis. Nat Rev Cancer 7: 165-168.
12. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310.
13. Choi J, Donehower LA (1999) p53 in embryonic development: maintaining a fine balance. Cell Mol Life Sci 55: 38-47.
14. Donehower LA, Harvey M, Slagle BT, McArthur MJ, Montgomery CA, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221.
15. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, et al. (1995) A subset of p53-deficient embryos exhibit exencephaly, Nat Genetics 10: 175-180.
16. Rotter V, Schwartz D, Almon E, Goldfinger N, Kapon A, et al. (1993) Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc Natl Acad Sci U S A 90: 9075-9079.
17. Beumer TL, Roepers-Gajadien HL, Gademan IS, van Buul PP, Gil-Gomez G, et al. (1998) The role of the tumor suppressor p53 in spermatogenesis. Cell Death Differ 5: 669-477.
18. Hu W, Feng Z, Teresky AK, Levine AJ (2007) p53 regulates maternal reproduction through LIF. Nature 450: 721-724.
19. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, et al. (2003) Links between Tumor Suppresors: p53 Is Required for TGF-[beta] Gene Responses by Cooperating with Smads. Cell 113: 301-314.
20. Chen J, Ruan H, Ng SM, Gao C, Soo HM, et al. (2005) Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafish. Genes Dev 19: 2900-2911.
21. Campbell WA, Yang H, Zetterberg H, Baulac S, Sears JA, et al. (2006) Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J Neurochem 96: 1423-1440.
22. Villiard E, Brinkmann H, Moiseeva O, Mallette FA, Ferbeyre G, et al. (2007) Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer. BMC Evol Biol 7: 180.
23. Almog N, Rotter V (1997) Involvement of p53 in cell differentiation and development. Biochim Biophys Acta 1333: F1-27.
24. Zambetti GP, Horwitz EM, Schipani E (2006) Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development J Cell Biol 172: 795-797.
25. Shaulsky G, Goldfinger N, Peled A, Rotter V (1991) Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci USA 88: 8982-8986.
26. Aloni-Grinstein R, Zan-Bar I, Alboum I, Goldfinger N, Rotter V (1993) Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene 8: 3297-3305.
27. Aloni-Grinstein R, Schwartz D, Rotter V (1995) Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. Embo J 14: 1392-1401.
28. Almog N, Rotter V (1997) Involvement of p53- in cell differentiation and development. Biochim Biophys Acta 1333: F1-27.
29. Huttinger-Kirchhof N, Cam. H, Griesmann H, Hofmann L, Beitzinger M, et al. (2006) The p53 family inhibitor Delta_Np73 interferes with multiple developmental programs. Cell Death Differ 13:174-177.
30. Wang X, Kua HY, Hu Y, Guo K, Zeng Q et al. (2006) p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol 172: 115-125.
31. Lengner CJ, Steinman HA, Gagnon J, Smith TW, Henderson JE, et al. (2006) Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 172: 909-921.
32. Tataria M, Quarto N, Longaker MT, Sylvester KG (2006) Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells. J Pediatr Surg 41: 624-632; discussion 624-632.
33. Cam H, Griesmann H, Beitzinger M, Hofmann L, Beinoraviciute-Kellner R, et al. (2006) p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 10: 281-293.
34. Porrello A, Cerone MA, Coen S, Gurtner A, Fontemaggi G, et al. (2000) p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol 151: 1295-1304.
35. Soddu S, Blandino G, Scardigli R, Coen S, Marchetti A, et al. (1996) Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol 134: 1-12.
36. Schwarzkopf M, Coletti D, Sassoon D, Marazzi G (2006) Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev 20: 3440-3452.
37. Constance CM, Morgan JIt, Umek RM (1996) C/EBPalpha regulation of the growth-arrest-associated gene gadd45. Mol Cell Biol 16: 3878-3883.
38. Berberich SJ, Litteral V, Mayo LD, Tabesh D, Morris D (1999) mdm-2 gene amplification in 3T3-L1 preadipocytes. Differentiation 64: 205-212.
39. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisledos F, Delaunay T, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
40. Benayahu D, Kletter Y, Zipori D, Wientroub S (1989) Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo. J Cell Physiol 140: 1-7.
41. Tanaka T, Yoshida N, Kishimoto T, Akira S (1997) Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. Embo J 16: 7432-7443
42. Rosen ED, MacDougald OA (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896.
43. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844-848.
44. Seargent JM, Yates EA, Gill JH (2004) GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation. Br J Pharmacol 143: 933-937.
45. Milyavsky M, Shats I, Cholostoy A, Brosh R, Buganim Y, et al. (2007) Inactivation of Myocardin and p16 during Malignant Transformation Contributes to a Differentiation Defect. Cancer Cell 11: 133-146.
46. Milyavsky M, Tabach Y, Shats I, Erez N, Cohen Y, et al. (2005) Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res 65: 4530-4543.
47. Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, et al. (1996) Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domain. Proc Natl Acad Sci U S A 93: 10309-10314.
48. Shats I, Milyavsky M, Cholostoy A, Brosh R, Rotter V (2007) Myocardin in tumor suppression and myofibroblast differentiation. Cell Cycle 6: 1141-1146.
49. Yaffe D, Saxel O (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
50. Slattery ML, Murtaugh MA, Sweeney C, Ma KN, Potter JD, et al. (2005) PPARgamma, energy balance, and associations with colon and rectal cancer. Nutr Cancer 51: 155-161.
51. Fajas L, Le Cam L, Polanowska J, Fabbrizio E, Servant N, et al. (2000) A CDE/CHR-like element mediates repression of transcription of the mouse RB2 (p130) gene. FEBS Lett 471: 29-33.
52. Lefebvre AM, Chen I, Desreumaux P, Najib J, Fruchart JC, et al. (1998) Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 4: 1053-1057.
53. Lefebvre M, Paulweber B, Fajas L, Woods J, McCrary C, et al. (1999) Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol 162: 331-340.
54. Saez E, Tontonoz P, Nelson MC, Alvarez JG, Ming UT, et al. (1998) Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat Med 4: 1058-1061.
55. Linsalata M, Giannini R, Notarnicola M, Cavallini A (2006) Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyl-transferase gene expressions are significantly correlated in human colorectal cancer. BMC Cancer 6: 191.
56. Yahagi N, Shimano H, Matsuzaka T, Najima Y, Sekiya M, et al. (2003) p53 Activation in adipocytes of obese mice. J Biol Chem 278: 25395-25400.
57. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, et al. (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53.
58. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, et al. (2006) p53 regulates mitochondrial respiration. Science 312: 1650-1653.
59. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, et al. (2007) A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 13: 992-997.
60. Milyavsky M, Shats I, Erez N, Tang X, Senderovich S, et al. (2003) Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res 63: 7147-7157.
61. Kochupurakkal BS, Sarig R, Fuchs O, Piestun D, Rechavi G, et al. (2008) Nanog inhibits the switch of myogenic cell towards the osteogenic lineage. Biochem Biophys Res Commun 365: 846-850.
62. Sarig R, Baruchi Z, Fuchs O, Nudel U, Yaffe D (2006) Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells. 24: 1769-1778.
63. Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, et al. (2007) Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109: 1422-1432.